Giulia Iovenitti
Siena, 53100, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
The Pyrazolo[3,4-d]Pyrimidine Derivative Si306 Encapsulated into Anti-GD2-Immunoliposomes as Therapeutic Treatment of Neuroblastoma.
Journal: Biomedicines
Published: February 14, 2022
Si113-prodrugs selectively activated by plasmin against hepatocellular and ovarian carcinoma.
Journal: European journal of medicinal chemistry
Published: March 18, 2021
AuNP Pyrazolo[3,4-d]pyrimidine Nanosystem in Combination with Radiotherapy against Glioblastoma.
Journal: ACS medicinal chemistry letters
Published: November 20, 2019
Identification of a new family of pyrazolo[3,4-d]pyrimidine derivatives as multitarget Fyn-Blk-Lyn inhibitors active on B- and T-lymphoma cell lines.
Journal: European journal of medicinal chemistry
Published: May 08, 2019
Rhodanine derivatives as potent anti-HIV and anti-HSV microbicides.
Journal: PloS one
Published: March 14, 2018
Plasmin-Binding Tripeptide-Decorated Liposomes Loading Pyrazolo[3,4-d]pyrimidines for Targeting Hepatocellular Carcinoma.
Journal: ACS medicinal chemistry letters
Published: February 08, 2018
Prodrugs of Pyrazolo[3,4-d]pyrimidines: From Library Synthesis to Evaluation as Potential Anticancer Agents in an Orthotopic Glioblastoma Model.
Journal: Journal of medicinal chemistry
Published: June 27, 2017
Showing 1-10 of 10
Last Updated: 09/26/2026